Literature DB >> 20554890

Dental pulp cells for induced pluripotent stem cell banking.

N Tamaoki1, K Takahashi, T Tanaka, T Ichisaka, H Aoki, T Takeda-Kawaguchi, K Iida, T Kunisada, T Shibata, S Yamanaka, K Tezuka.   

Abstract

Defined sets of transcriptional factors can reprogram human somatic cells to induced pluripotent stem (iPS) cells. However, many types of human cells are not easily accessible to minimally invasive procedures. Here we evaluated dental pulp cells (DPCs) as an optimal source of iPS cells, since they are easily obtained from extracted teeth and can be expanded under simple culture conditions. From all 6 DPC lines tested with the conventional 3 or 4 reprogramming factors, iPS cells were effectively established from 5 DPC lines. Furthermore, determination of the HLA types of 107 DPC lines revealed 2 lines homozygous for all 3 HLA loci and showed that if an iPS bank is established from these initial pools, the bank will cover approximately 20% of the Japanese population with a perfect match. Analysis of these data demonstrates the promising potential of DPC collections as a source of iPS cell banks for use in regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554890     DOI: 10.1177/0022034510366846

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  66 in total

Review 1.  Dental pulp tissue engineering.

Authors:  Flávio Fernando Demarco; Marcus Cristian Muniz Conde; Bruno Neves Cavalcanti; Luciano Casagrande; Vivien Thiemy Sakai; Jacques Eduardo Nör
Journal:  Braz Dent J       Date:  2011

Review 2.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

3.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

Review 4.  Methods of induced pluripotent stem cells for clinical application.

Authors:  Tomohisa Seki; Keiichi Fukuda
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 5.  Dental pulp stem cells for the study of neurogenetic disorders.

Authors:  A Kaitlyn Victor; Lawrence T Reiter
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

6.  Generation of induced pluripotent stem cells with high efficiency from human embryonic renal cortical cells.

Authors:  Ling Yao; Ruifang Chen; Pu Wang; Qi Zhang; Hailiang Tang; Huaping Sun
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

7.  Comparison of the characteristics of mesenchymal stem-like cells derived by integration-free induced pluripotent stem cells in different single-cell culture media under feeder-free conditions.

Authors:  Mamoru Ueda; Yoshiya Hashimoto; Yoshitomo Honda; Shunsuke Baba; Shosuke Morita
Journal:  Med Mol Morphol       Date:  2018-11-16       Impact factor: 2.309

8.  Mouse embryonic fibroblast (MEF)/BMP4-conditioned medium enhanced multipotency of human dental pulp cells.

Authors:  Lu Liu; Zhengjun Peng; Zhezhen Xu; Haoquan Huang; Xi Wei
Journal:  J Mol Histol       Date:  2017-12-06       Impact factor: 2.611

Review 9.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

10.  Gingival fibroblasts as a promising source of induced pluripotent stem cells.

Authors:  Hiroshi Egusa; Keisuke Okita; Hiroki Kayashima; Guannan Yu; Sho Fukuyasu; Makio Saeki; Takuya Matsumoto; Shinya Yamanaka; Hirofumi Yatani
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.